Huvepharma announces terms on €275m buyout loan
Huvepharma, the Bulgarian pharmaceutical company, is raising a €275m loan to back the Domuschiev family’s outright purchase of the company.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts